Showing results (2111-2120 of 4,519) with videos related to

Sort By:
Pageof 452
Advances in Therapy|August 14, 2024
Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysisPaschalis Karakasis, Nikolaos Fragakis, Dimitrios Patoulias, et al.
Advances in Therapy|August 20, 2024
Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese PopulationLise Retat, Dunming Xiao, Laura Webber, et al.
Advances in Therapy|October 19, 2024
A Podcast on Patient and Physician Perspectives on the Management of Endometriosis and Relugolix Combination TherapyTara Mangum, Sanjay K Agarwal
Advances in Therapy|August 2, 2024
Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative ReviewFernando Gómez-Peralta, Isabel Leiva-Gea, Natalia Duque, et al.
Advances in Therapy|May 8, 2025
Evaluation of Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Chronic Refractory Gout in the United StatesNana Kragh, Andrew Worsfold, Abiola Oladapo, et al.
Advances in Therapy|May 22, 2025
Shared Decision-Making for Restoring Trust in the Management of Atherosclerotic Cardiovascular Disease in the Post-pandemic EraWarren J Wexelman, Nicole Ciffone, Nishant P Shah
Advances in Therapy|April 29, 2025
The Impacts of Caregiving for Patients with X-Linked Retinitis Pigmentosa (XLRP): Findings from the EXPLORE XLRP-2 StudyMichel Weber, Francesco Parmeggiani, Dominique Bremond-Gignac, et al.
Advances in Therapy|April 25, 2025
LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan AreaLiming Zhao, Jiamei Liu, Yin Liu, et al.
Advances in Therapy|March 27, 2025
Fertility Outcomes in Risdiplam-Treated Male Patients with Spinal Muscular Atrophy: A Multicenter Case SeriesShelley Coskery, Marcus Erdler, Margaret R Frey, et al.
Advances in Therapy|March 28, 2025
Loncastuximab Tesirine Versus Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory DLBCL After ≥ 2 Lines of Therapy: Matching-Adjusted Indirect ComparisonKoo Wilson, Francesca Chiodi, Abby Paine, et al.
Pageof 452